Purchases and Sales Made in Q2 2023 in Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS) during Q2 2023. The information is specifically focused on institutions that hold shares of Aclaris Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 04, 2023
Q2 2023
|
Simplex Trading, LLC
|
SELL
|
- |
-123K- 98.13% |
$973K - $1.31M
|
2.34K
$8.9K
|
|
|
Aug 14, 2023
Q2 2023
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-125K- 55.13% |
$984K - $1.33M
|
101K
$386K
|
|
|
Aug 14, 2023
Q2 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-180K- 15.25% |
$1.42M - $1.92M
|
1M
$3.8M
|
|
|
Aug 14, 2023
Q2 2023
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
- |
-187K- 84.45% |
$1.47M - $1.99M
|
34.4K
$131K
|
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-283K- 22.57% |
$2.23M - $3.01M
|
970K
$3.68M
|
|
|
Aug 14, 2023
Q2 2023
|
Braidwell LP
Stamford, CT |
SELL
|
- |
-368K- 11.25% |
$2.9M - $3.91M
|
2.9M
$11M
|
|
|
Aug 14, 2023
Q2 2023
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
- |
-390K- 93.63% |
$3.08M - $4.15M
|
26.6K
$101K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-495K- 15.92% |
$3.9M - $5.26M
|
2.61M
$9.93M
|